Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiotypic vaccination in B-cell malignancies

A Bianchi1, M Massaia

  • 1Dipartimento di Medicina e Oncologia Sperimentale, Azienda Ospedaliera San Giovanni Battista di Torino, Italy.

Molecular Medicine Today
|November 14, 1997
PubMed
Summary

Idiotypic vaccination targets unique tumor antigens in B-cell malignancies. This immunotherapy approach, utilizing novel immunogens and antigen-presenting cells, is now used clinically for lymphoma and multiple myeloma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nitric oxide is involved in the expression of neocortical spike-and-wave spindling episodes in DBA/2J mice.

The Journal of pharmacy and pharmacology·2003
Same author

Delayed presentation of congenital diaphragmatic Bochdalek hernia. Case report.

Minerva pediatrica·2003
Same author

Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy.

Neurology·2003
Same author

Family study of epilepsy in first degree relatives: data from the Italian Episcreen Study.

Seizure·2003
Same author

Alterations in smooth muscle contractile and cytoskeleton proteins and interstitial cells of Cajal in megacystis microcolon intestinal hypoperistalsis syndrome.

Journal of pediatric surgery·2003
Same author

Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord.

Journal of chemical neuroanatomy·2003

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Immunoglobulins possess unique portions called idiotypes, which can function as tumor-specific antigens in B-cell malignancies.
  • Idiotypes represent promising targets for developing effective vaccine immunotherapies against cancers.

Purpose of the Study:

  • To explore the potential of idiotypic vaccination as a therapeutic strategy for B-cell malignancies.
  • To review advancements in idiotype immunogenicity enhancement and clinical applications.

Main Methods:

  • Utilizing haptens and adjuvants like cytokines to boost idiotype immunogenicity in animal models.
  • Employing DNA technology to create advanced immunogens such as fusion proteins and naked-DNA vaccines.
  • Investigating the role of antigen-presenting cells in initiating anti-idiotype immune responses.

Main Results:

  • Successful establishment of protective anti-idiotype immunity in preclinical models.
  • Development of novel immunogens including fusion proteins and DNA vaccines.
  • Recognition of antigen-presenting cells' critical role in immune response initiation.

Conclusions:

  • Idiotypic vaccination has evolved from experimental models to clinical application.
  • The approach is now utilized in treating patients with lymphoma and multiple myeloma.
  • Idiotypic vaccination represents a significant advancement in cancer immunotherapy.

Related Experiment Videos